MCFD2
protein-codingmultiple coagulation factor deficiency 2, ER cargo receptor complex subunit, the group of EF-hand domain containing
Gene summary
This gene encodes a soluble luminal protein with two calmodulin-like EF-hand motifs at its C-terminus. This protein forms a complex with LMAN1 (lectin mannose binding protein 1; also known as ERGIC-53) that facilitates the transport of coagulation factors V (FV) and VIII (FVIII) from the endoplasmic reticulum to the Golgi apparatus via an endoplasmic reticulum Golgi intermediate compartment (ERGIC). Mutations in this gene cause combined deficiency of FV and FVIII (F5F8D); a rare autosomal recessive bleeding disorder characterized by mild to moderate bleeding and coordinate reduction in plasma FV and FVIII levels. This protein has also been shown to maintain stem cell potential in adult central nervous system and is a marker for testicular germ cell tumors. The 3' UTR of this gene contains a transposon-like human repeat element named 'THE 1'. A processed RNA pseudogene of this gene is on chromosome 6p22.1. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Apr 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~40.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013331
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0013331
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013331
Submitter: ClinGen
MCFD2 was first reported in relation to autosomal recessive factor V and factor VIII, combined deficiency in 2003 (Zhang B, et al., 2003, PMID: 12717434). At least 21 unique variants (including missense, nonsense, frameshift, and splicing) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 9 probands in 2 publications (PMIDs: 12717434, 17610559). More evidence is available in the literature, but the maximum score for genetic evidence has been reached. This gene disease association is supported by its biochemical function as a cargo receptor for the ER-to-Golgi transport of factor V and factor VIII ( PMID: 15886209), its interaction with LMAN1 (PMID: 12717434) which is also implicated in this disease, and a knockout mouse model (PMID: 29735583) that also exhibits reductions of both factor V and factor VIII. In summary, MCFD2 is definitively associated with autosomal recessive inheritance of factor V and factor VIII, combined deficiency. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0013331
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013331
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0018175
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Hematologic
Intervention: Hematologic
Rationale: Preventive measures and prompt treatment of bleeding diathese may reduce morbidity; Medical treatment to replace absent factors can be effective (eg, with FFP for FV, Desmopression or FVIII concentrates/recombinant products/plasma-derived factor for FVIII)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MCFD2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_139279.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 1 | 4 | |||
| missense | 3 | 2 | 35 | 1 | 41 | |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | 4 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | 4 | ||
| Total | 6 | 5 | 40 | 2 | 0 | 53 |
Highest pathogenic variant AF is 0.000017967113
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_644808.1 | 3 | MANE Select | |
| Ensembl | ENSP00000317271.4 | 3 | MANE Select | |
| RefSeq | NP_001164977.1 | 3 | Standard | |
| RefSeq | NP_001164978.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Vesicle-mediated transport
- Membrane Trafficking
- Post-translational protein modification
- Metabolism of proteins
- Cargo concentration in the ER
Biological Process
- endoplasmic reticulum to Golgi vesicle-mediated transport
- protein transport
- COPII vesicle coating
Molecular Function
- calcium ion binding
- protein binding
Cellular Component
- Golgi membrane
- endoplasmic reticulum membrane
- ER to Golgi transport vesicle membrane
- endoplasmic reticulum-Golgi intermediate compartment membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000409105
- Coding exons
- 3
- Length
- 39986
- Individuals with no LoFs
- 125737
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 10
- Defined
- 125747
- p
- 0.0000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.575 | 91 | 76.8 | 1.18 | 0.00000378 | 978 |
| Missense (PolyPhen) | 15 | 17.979 | 0.8343 | 275 | ||
| Synonymous | -0.519 | 36 | 32.2 | 1.12 | 0.00000188 | 267 |
| Loss of Function | 1.21 | 2 | 4.87 | 0.411 | 2.10e-7 | 64 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000026 | 0.000026 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: The MCFD2-LMAN1 complex forms a specific cargo receptor for the ER-to-Golgi transport of selected proteins. Plays a role in the secretion of coagulation factors. {ECO:0000269|PubMed:12717434}.;
- Disease
- DISEASE: Factor V and factor VIII combined deficiency 2 (F5F8D2) [MIM:613625]: A blood coagulation disorder characterized by bleeding symptoms similar to those in hemophilia or parahemophilia, that are caused by single deficiency of FV or FVIII, respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma levels of coagulation factors V and VIII are in the range of 5 to 30% of normal. {ECO:0000269|PubMed:12717434, ECO:0000269|PubMed:18590741, ECO:0000269|PubMed:18685427, ECO:0000269|PubMed:20491958}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- LoFtool
- 0.0726
- RVIS EVS
- -0.16
- RVIS percentile EVS
- 41.25
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.903
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |